Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot2 - STU 1 ballot
Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot2 - STU 1 ballot
Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot2 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions
{
"resourceType" : "Evidence",
"id" : "379741",
"meta" : {
"versionId" : "3",
"lastUpdated" : "2025-07-01T16:47:40.277Z"
},
"text" : {
"status" : "extensions",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: Evidence 379741</b></p><a name=\"379741\"> </a><a name=\"hc379741\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">version: 3; Last updated: 2025-07-01 16:47:40+0000</p></div><p><b>ArtifactPublicationStatus</b>: <span title=\"Codes:{http://terminology.hl7.org/CodeSystem/cited-artifact-status-type active}\">Active</span></p><p><b>url</b>: <a href=\"https://fevir.net/resources/Evidence/379741\">https://fevir.net/resources/Evidence/379741</a></p><p><b>identifier</b>: FEvIR Object Identifier/379741</p><p><b>name</b>: Evidence_for_Results_for_Add_on_Amlodipine_at_6_weeks_in_GroupAssignment_Quadpill_vs_Candesartan</p><p><b>title</b>: Evidence for Results for Add-on Amlodipine at 6 weeks in GroupAssignment: Quadpill vs. Candesartan</p><p><b>citeAs</b>: </p><div><p>Evidence for Results for Add-on Amlodipine at 6 weeks in GroupAssignment: Quadpill vs. Candesartan [Database Entry: FHIR Evidence Resource]. Contributors: Joanne Dehnbostel [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 379741. Revised 2025-07-01. Available at: https://fevir.net/resources/Evidence/379741. Computable resource at: https://fevir.net/resources/Evidence/379741#json.</p>\n</div><p><b>status</b>: Active</p><p><b>author</b>: Joanne Dehnbostel: </p><p><b>publisher</b>: Computable Publishing LLC</p><p><b>contact</b>: <a href=\"mailto:support@computablepublishing.com\">support@computablepublishing.com</a></p><p><b>copyright</b>: </p><div><p>https://creativecommons.org/licenses/by-nc-sa/4.0/</p>\n</div><h3>RelatesTos</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Type</b></td><td><b>Target[x]</b></td></tr><tr><td style=\"display: none\">*</td><td>Part Of</td><td><a href=\"Composition-375280.html\">Outcome Measure Report for QUARTET USA Trial</a></td></tr></table><p><b>description</b>: </p><div><p>This Evidence Resource is referenced in an example for the EBMonFHIR Implementation Guide.</p>\n</div><blockquote><p><b>variableDefinition</b></p><p><b>variableRole</b>: Population</p><p><b>observed</b>: <a href=\"EvidenceVariable-375183.html\">GroupAssignment: Quadpill vs. Candesartan</a></p></blockquote><blockquote><p><b>variableDefinition</b></p><p><b>variableRole</b>: Outcome</p><p><b>observed</b>: <a href=\"EvidenceVariable-375203.html\">Add-on Amlodipine at 6 weeks</a></p></blockquote><blockquote><p><b>statistic</b></p><p><b>statisticType</b>: <span title=\"Codes:{https://fevir.net/sevco STATO:0000182}\">odds ratio</span></p><p><b>quantity</b>: 0.08</p><p><b>numberAffected</b>: 22</p><h3>SampleSizes</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Extension</b></td><td><b>NumberOfParticipants</b></td><td><b>KnownDataCount</b></td></tr><tr><td style=\"display: none\">*</td><td/><td>62</td><td>60</td></tr></table><blockquote><p><b>attributeEstimate</b></p><p><b>type</b>: <span title=\"Codes:{https://fevir.net/sevco STATO:0000196}\">confidence interval</span></p><p><b>level</b>: 0.95</p><p><b>range</b>: 0.02-0.41</p></blockquote><blockquote><p><b>attributeEstimate</b></p><p><b>type</b>: <span title=\"Codes:{https://fevir.net/sevco STATO:0000700}\">p-value</span></p><p><b>quantity</b>: 0.003</p></blockquote></blockquote></div>"
},
"extension" : [
{
"url" : "http://hl7.org/fhir/uv/ebm/StructureDefinition/artifact-publication-status",
"valueCodeableConcept" : {
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/cited-artifact-status-type",
"code" : "active",
"display" : "Active"
}
]
}
}
],
"url" : "https://fevir.net/resources/Evidence/379741",
"identifier" : [
{
"type" : {
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/v2-0203",
"code" : "ACSN",
"display" : "Accession ID"
}
],
"text" : "FEvIR Object Identifier"
},
"system" : "https://fevir.net/FOI",
"value" : "379741",
"assigner" : {
"display" : "Computable Publishing LLC"
}
}
],
"name" : "Evidence_for_Results_for_Add_on_Amlodipine_at_6_weeks_in_GroupAssignment_Quadpill_vs_Candesartan",
"title" : "Evidence for Results for Add-on Amlodipine at 6 weeks in GroupAssignment: Quadpill vs. Candesartan",
"citeAs" : "Evidence for Results for Add-on Amlodipine at 6 weeks in GroupAssignment: Quadpill vs. Candesartan [Database Entry: FHIR Evidence Resource]. Contributors: Joanne Dehnbostel [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 379741. Revised 2025-07-01. Available at: https://fevir.net/resources/Evidence/379741. Computable resource at: https://fevir.net/resources/Evidence/379741#json.",
"status" : "active",
"author" : [
{
"name" : "Joanne Dehnbostel"
}
],
"publisher" : "Computable Publishing LLC",
"contact" : [
{
"telecom" : [
{
"system" : "email",
"value" : "support@computablepublishing.com"
}
]
}
],
"copyright" : "https://creativecommons.org/licenses/by-nc-sa/4.0/",
"relatesTo" : [
{
"type" : "part-of",
"targetReference" : {
🔗 "reference" : "Composition/375280",
"type" : "Composition",
"display" : "Outcome Measure Report for QUARTET USA Trial"
}
}
],
"description" : "This Evidence Resource is referenced in an example for the EBMonFHIR Implementation Guide.",
"variableDefinition" : [
{
"variableRole" : "population",
"observed" : {
🔗 "reference" : "EvidenceVariable/375183",
"type" : "EvidenceVariable",
"display" : "GroupAssignment: Quadpill vs. Candesartan"
}
},
{
"variableRole" : "outcome",
"observed" : {
🔗 "reference" : "EvidenceVariable/375203",
"type" : "EvidenceVariable",
"display" : "Add-on Amlodipine at 6 weeks"
}
}
],
"statistic" : [
{
"statisticType" : {
"coding" : [
{
"system" : "https://fevir.net/sevco",
"code" : "STATO:0000182",
"display" : "odds ratio"
}
]
},
"quantity" : {
"value" : 0.08
},
"numberAffected" : 22,
"sampleSize" : {
"extension" : [
{
"url" : "http://hl7.org/fhir/uv/ebm/StructureDefinition/number-analyzed",
"valueUnsignedInt" : 60
}
],
"numberOfParticipants" : 62,
"knownDataCount" : 60
},
"attributeEstimate" : [
{
"type" : {
"coding" : [
{
"system" : "https://fevir.net/sevco",
"code" : "STATO:0000196",
"display" : "confidence interval"
}
]
},
"level" : 0.95,
"range" : {
"low" : {
"value" : 0.02
},
"high" : {
"value" : 0.41
}
}
},
{
"type" : {
"coding" : [
{
"system" : "https://fevir.net/sevco",
"code" : "STATO:0000700",
"display" : "p-value"
}
]
},
"quantity" : {
"value" : 0.003
}
}
]
}
]
}
IG © 2024+ HL7 International / Clinical Decision Support. Package hl7.fhir.uv.ebm#1.0.0-ballot2 based on FHIR 6.0.0-ballot3. Generated 2025-09-04
Links: Table of Contents |
QA Report
| Version History |
|
Propose a change